These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A. Oncogene; 2005 Feb 03; 24(6):1098-103. PubMed ID: 15592505 [Abstract] [Full Text] [Related]
7. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S. Cancer Res; 2010 May 15; 70(10):4233-42. PubMed ID: 20442281 [Abstract] [Full Text] [Related]
8. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. Døsen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E. BMC Immunol; 2006 Jun 29; 7():13. PubMed ID: 16808837 [Abstract] [Full Text] [Related]
9. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE, Wang MX, Li RQ. Cancer Invest; 2009 Jul 29; 27(6):604-12. PubMed ID: 19440933 [Abstract] [Full Text] [Related]
10. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin. Tanahashi J, Daa T, Yada N, Kashima K, Kondoh Y, Yokoyama S. J Oral Pathol Med; 2008 Oct 29; 37(9):565-70. PubMed ID: 18284543 [Abstract] [Full Text] [Related]
11. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY, Wang ZM, Li-Chen, Wang BL, Shen ZZ, Huang W, Shao ZM. Breast Cancer Res Treat; 2010 Feb 29; 119(3):601-12. PubMed ID: 19301122 [Abstract] [Full Text] [Related]
13. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells. Rider V, Isuzugawa K, Twarog M, Jones S, Cameron B, Imakawa K, Fang J. J Endocrinol; 2006 Dec 29; 191(3):537-48. PubMed ID: 17170212 [Abstract] [Full Text] [Related]
14. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Khan NI, Bradstock KF, Bendall LJ. Br J Haematol; 2007 Aug 29; 138(3):338-48. PubMed ID: 17614820 [Abstract] [Full Text] [Related]
15. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A, Gross N. Oncogene; 2009 Jun 11; 28(23):2245-56. PubMed ID: 19421142 [Abstract] [Full Text] [Related]
16. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines]. Kulikova KV, Posviatenko AV, Gnuchev NV, Georgiev GP, Kibardin AV, Larin SS. Mol Biol (Mosk); 2011 Jun 11; 45(5):884-91. PubMed ID: 22393786 [Abstract] [Full Text] [Related]
17. Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. Kirikoshi H, Katoh M. Int J Oncol; 2002 Oct 11; 21(4):895-900. PubMed ID: 12239632 [Abstract] [Full Text] [Related]
18. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Oncogene; 2002 Aug 15; 21(36):5548-56. PubMed ID: 12165853 [Abstract] [Full Text] [Related]
19. Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2+-mobilization in Human Embryonic Kidney 293 cells. Verkaar F, van Rosmalen JW, Smits JF, Blankesteijn WM, Zaman GJ. Cell Signal; 2009 Jan 15; 21(1):22-33. PubMed ID: 18929644 [Abstract] [Full Text] [Related]
20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF. Int J Oncol; 2005 Oct 15; 27(4):949-56. PubMed ID: 16142310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]